Why the study?
Does continuous regular use of beta blockers for 2 years reduce major adverse events in patients with AMI after PCI?
Does continuous regular use of beta blockers for 2 years reduce major adverse events in patients with AMI after PCI?
Continuous regular use of beta blockers for 2 years after AMI and PCI is associated with a reduction in major adverse events.
May support beta-blocker continuation post-AMI; leaves open randomized confirmation after PCI.
Prescription of beta blocker in patients with AMI after PCI was sequentially increased. Continuous regular use of beta blocker for 2 years after AMI reduced major adverse events compared to no use of beta blocker.
No takes yet. Share an insight, caveat, or question.
Won et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: